The study targets patients with refractory, unresectable microsatellite-stable (MSS)/mismatch repair proficient (pMMR) metastatic colorectal cancer (mCRC)
Ac-225, an alpha-emitting radionuclide, can be paired with molecules designed to selectively target cancer cells.
Empowering 15 Women in STEM (Life Sciences) with scholarship, internship and mentorship
The approval is backed by results from Lilly’s ATTAIN clinical trial program, which showed significant weight loss among participants
The new regimen, delivering 50 mg/5 mL and 28 mg/5 mL doses, offers a higher concentration of the drug for both loading and maintenance phases
The showcase, running March 27–31, puts a spotlight on everything from fine lines to daily sun protection
The decision is based on the phase 3 DESTINY-Breast11 trial
Sugammadex injection is bioequivalent to Merck’s Bridion injection for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adults and pediatric patients aged 2 years and older undergoing surgery
Price of the starting dose of Ozempic and Wegovy reduced by 36% and 48% respectively
The presentations underscore the company’s deep expertise in dermatology and immunology
Subscribe To Our Newsletter & Stay Updated
